COMMUNIQUÉS West-GlobeNewswire

Aptinyx Salutes Retiring Chief Scientific Officer and NMDA Receptor Drug Discovery Pioneer, Joseph Moskal
12/07/2019
EVANSTON, Ill., July 12, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]
Medovex Corporation Announces Name Change to H-CYTE and New Ticker Symbol
12/07/2019
Company’s Shares to Trade Under Symbol “HCYT” at Opening of Trading on July 15, 2019 TAMPA, Fla., July 12, 2019 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: MDVX), today announced that FINRA has approved the effectiveness [...]
Middlefield Health & Wellness ETF Distributions
12/07/2019
CALGARY, Alberta, July 12, 2019 (GLOBE NEWSWIRE) -- Middlefield Health & Wellness ETF (TSX: HWF) (the “Fund”) is pleased to announce that distributions for the third quarter of 2019 will be payable to unitholders of [...]
RAFARMA Welcomes New CEO Vladimir Dolgolenko
12/07/2019
Ljubljana, Slovenia, July 12, 2019 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to the appointment of Vladimir Dolgolenko as its new CEO and President. Mr. Srečo Bojt shall remain as a company [...]
Le Dr Seth Forman a été nommé pour présider la seconde étude de phase 2 sur le bermekimab de XBiotech dans la dermatite atopique
12/07/2019
Une prochaine étude randomisée, en double aveugle et contrôlée contre placebo de phase 2 suit l'étude ouverte réussie sur la dermatite atopique (DA) AUSTIN, Texas, 12 juill. 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ : [...]
CureVac to Participate in Two Panels at the ROTH RNA Revolution Conference
12/07/2019
TÜBINGEN, Germany and BOSTON, July 12, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Dan Menichella, Chief Executive [...]
Genmab and BliNK Biomedical Enter into Commercial License Agreement
12/07/2019
Media Release Copenhagen, Denmark, July 12, 2019 Genmab and BliNK Biomedical have entered into a commercial license agreement to develop novel bispecific therapeutics based on BliNK Biomedical’s CD47 antibodies and [...]
Monthly information regarding the total number of voting rights and total number of shares of the Company
12/07/2019
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
12/07/2019
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
Notice Convening the Extraordinary General Meeting
12/07/2019
July 12, 2019 Announcement no. 13 NOTICE CONVENING THE EXTRAORDINARY GENERAL MEETING The Board of Directors hereby convenes an Extraordinary General Meeting of BioPorto A / S (the “Company”): August 15, 2019, at 2.00 pm [...]
C-RAD and Elekta sign agreement to distribute C-RAD’s cutting-edge SIGRT solutions in America
12/07/2019
C-RAD and Elekta announced today a sales and distribution agreement for the North American and Mexican market. The agreement enables Elekta to offer C-RAD’s surface image guided radiation therapy (SIGRT) technology for [...]
ObsEva SA to Host Key Opinion Leader Meeting on In Vitro Fertilization (IVF) July 17, 2019 in New York City
12/07/2019
Geneva, Switzerland and Boston, MA – July 12, 2019 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
Editorial on Positive Data for BARHEMSYS® Treatment of Post-Operative Nausea & Vomiting (PONV) Published in Anesthesia & Analgesia
12/07/2019
Cambridge, UK and Indianapolis, US – 12 July 2019: Acacia Pharma Group plc (“Acacia Pharma”, the “Company”) (EURONEXT: ACPH) welcomes an editorial published in the leading peer-reviewed journal Anesthesia & [...]
Ascent Industries Provides Update on the Supreme Court of British Columbia in the Matter of the Companies Creditor Arrangement Act
12/07/2019
VANCOUVER, British Columbia, July 11, 2019 (GLOBE NEWSWIRE) -- Ascent Industries Corp. ( CSE: ASNT ) (“ Ascent ” or the “ Company ”) is providing an update on the Supreme Court of British Columbia hearing, in the matter [...]
Cytori to Present Corporate Update & New Strategic Direction
12/07/2019
SAN DIEGO, July 11, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) “the Company” will provide a live webcast to discuss its new company direction following two recent asset sales and highlight key [...]
MediciNova Announces Phase 3 Clinical Trial Plan for MN-166 (ibudilast) in Progressive MS
12/07/2019
LA JOLLA, Calif., July 11, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
Correction - Avricore Health Announces Amendment to Placement Terms
12/07/2019
A correction from source is issued for the news release of even date. The news release has been corrected for the Warrant and Finder Warrant exercise prices. The corrected release follows: NOT FOR DISSEMINATION IN THE [...]
Dentsply Sirona to Host Second Quarter 2019 Conference Call on August 2nd
11/07/2019
CHARLOTTE, N.C., July 11, 2019 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (NASDAQ:XRAY), The Dental Solutions Company™, today announced that the Company will host an investor conference call and live webcast on Friday, [...]
Ritter Pharmaceuticals Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
11/07/2019
Ritter Shares Will Continue to Trade on the Nasdaq Capital Market LOS ANGELES, July 11, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of [...]

Pages